JP2024534124A5 - - Google Patents
Info
- Publication number
- JP2024534124A5 JP2024534124A5 JP2024512008A JP2024512008A JP2024534124A5 JP 2024534124 A5 JP2024534124 A5 JP 2024534124A5 JP 2024512008 A JP2024512008 A JP 2024512008A JP 2024512008 A JP2024512008 A JP 2024512008A JP 2024534124 A5 JP2024534124 A5 JP 2024534124A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- nucleic acid
- acid molecule
- molecule according
- bacmid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163236215P | 2021-08-23 | 2021-08-23 | |
| US63/236,215 | 2021-08-23 | ||
| PCT/US2022/075280 WO2023028455A1 (en) | 2021-08-23 | 2022-08-22 | Closed-end dna production with inverted terminal repeat sequences |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534124A JP2024534124A (ja) | 2024-09-18 |
| JP2024534124A5 true JP2024534124A5 (enExample) | 2025-08-29 |
Family
ID=83849025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024512008A Pending JP2024534124A (ja) | 2021-08-23 | 2022-08-22 | 逆位末端反復配列によるクローズドエンドｄｎａの作製 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230091932A1 (enExample) |
| EP (1) | EP4392445A1 (enExample) |
| JP (1) | JP2024534124A (enExample) |
| KR (1) | KR20240049825A (enExample) |
| CN (1) | CN117881696A (enExample) |
| AR (1) | AR126845A1 (enExample) |
| AU (1) | AU2022334714A1 (enExample) |
| CA (1) | CA3229345A1 (enExample) |
| CO (1) | CO2024001242A2 (enExample) |
| IL (1) | IL310963A (enExample) |
| MX (1) | MX2024002192A (enExample) |
| TW (1) | TW202328174A (enExample) |
| WO (1) | WO2023028455A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ762100A (en) | 2017-08-09 | 2025-12-19 | Bioverativ Therapeutics Inc | Nucleic acid molecules and uses thereof |
| EP3833766A1 (en) | 2018-08-09 | 2021-06-16 | Bioverativ Therapeutics Inc. | Nucleic acid molecules and uses thereof for non-viral gene therapy |
| CA3262218A1 (en) | 2022-07-19 | 2024-01-25 | Rampart Bioscience, Inc. | CIRCULAR NON-IMMUNOGENEOUS NON-VIRAL DNA VECTORS |
| EP4692314A1 (en) * | 2023-03-24 | 2026-02-11 | Nanjing GenScript Biotech Co., Ltd. | Host cell for improving stability of plasmid |
| WO2024249298A2 (en) * | 2023-05-26 | 2024-12-05 | Generation Bio Co. | Modified closed-ended dna (cedna) vectors, compositions, and uses thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4704362A (en) | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
| EP0832981A1 (en) | 1987-02-17 | 1998-04-01 | Pharming B.V. | DNA sequences to target proteins to the mammary gland for efficient secretion |
| US5633076A (en) | 1989-12-01 | 1997-05-27 | Pharming Bv | Method of producing a transgenic bovine or transgenic bovine embryo |
| MX9204374A (es) | 1991-07-25 | 1993-03-01 | Idec Pharma Corp | Anticuerpo recombinante y metodo para su produccion. |
| ATE236987T1 (de) | 1992-11-13 | 2003-04-15 | Idec Pharma Corp | Konsensus-kozak-sequenzen zur säugetier- exprimierung |
| US5736137A (en) | 1992-11-13 | 1998-04-07 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
| GB9524973D0 (en) | 1995-12-06 | 1996-02-07 | Lynxvale Ltd | Viral vectors |
| AU737155B2 (en) | 1997-03-14 | 2001-08-09 | Biogen Idec Inc. | Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
| GB0911870D0 (en) * | 2009-07-08 | 2009-08-19 | Ucl Business Plc | Optimised coding sequence and promoter |
| WO2014168953A1 (en) * | 2013-04-08 | 2014-10-16 | University Of Iowa Research Foundation | Chimeric adeno-associated virus/ bocavirus parvovirus vector |
| SMT202000531T1 (it) * | 2014-03-09 | 2020-11-10 | Univ Pennsylvania | Composizioni utili in trattamento di deficit di ornitina transcarbamilasi(otc) |
| TWI707951B (zh) | 2015-04-08 | 2020-10-21 | 美商健臻公司 | 過大腺相關載體之製造 |
| EP3687580A1 (en) * | 2017-09-27 | 2020-08-05 | Sigilon Therapeutics, Inc. | Methods, compositions, and implantable elements comprising active cells |
| EP3736286A1 (en) * | 2019-05-09 | 2020-11-11 | Biotest AG | Single chain factor viii molecule |
| JP2023535632A (ja) * | 2020-07-27 | 2023-08-18 | アンジャリウム バイオサイエンシズ エージー | Ｄｎａ分子の組成物、その作製方法、及びその使用方法 |
-
2022
- 2022-08-22 EP EP22793615.0A patent/EP4392445A1/en active Pending
- 2022-08-22 US US17/821,356 patent/US20230091932A1/en active Pending
- 2022-08-22 MX MX2024002192A patent/MX2024002192A/es unknown
- 2022-08-22 CA CA3229345A patent/CA3229345A1/en active Pending
- 2022-08-22 JP JP2024512008A patent/JP2024534124A/ja active Pending
- 2022-08-22 AU AU2022334714A patent/AU2022334714A1/en active Pending
- 2022-08-22 AR ARP220102259A patent/AR126845A1/es unknown
- 2022-08-22 KR KR1020247009558A patent/KR20240049825A/ko active Pending
- 2022-08-22 CN CN202280057094.9A patent/CN117881696A/zh active Pending
- 2022-08-22 IL IL310963A patent/IL310963A/en unknown
- 2022-08-22 TW TW111131532A patent/TW202328174A/zh unknown
- 2022-08-22 WO PCT/US2022/075280 patent/WO2023028455A1/en not_active Ceased
-
2024
- 2024-02-06 CO CONC2024/0001242A patent/CO2024001242A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024534124A5 (enExample) | ||
| US20240109938A1 (en) | Recombinant aav1, aav5, and aav6 capsid mutants and uses thereof | |
| AU2019200949B2 (en) | High-transduction-efficiency raav vectors, compositions, and methods of use | |
| US20230129762A1 (en) | High-transduction-efficiency raav vectors, compositions, and methods of use | |
| US9611302B2 (en) | High-transduction-efficiency RAAV vectors, compositions, and methods of use | |
| JP7413256B2 (ja) | 神経変性疾患の遺伝子治療 | |
| JP2022517174A5 (enExample) | ||
| JP2024150613A (ja) | 変異ａａｖ、及び、細胞、臓器並びに組織への遺伝子導入のための組成物、方法並びに使用法 | |
| JP2020537544A5 (enExample) | ||
| JP2020537542A5 (enExample) | ||
| CN104520428A (zh) | 将基因转移到细胞、器官和组织的aav载体组合物和方法 | |
| JP7785389B2 (ja) | 新規なイントロン断片 | |
| JP2024532261A5 (enExample) | ||
| EP3613856A1 (en) | Shrna expression cassette, polynucleotide sequence carrying same, and application thereof | |
| CN108239645B (zh) | 肝脏特异性转录调控序列及其应用 | |
| JP2023551254A5 (enExample) | ||
| RU2024107452A (ru) | Получение днк с замкнутыми концами с последовательностями инвертированных концевых повторов | |
| WO2025065890A1 (zh) | 一种重组腺相关病毒颗粒、重组腺相关病毒载体系统及其应用 | |
| CN120981475A (zh) | 变体aav9衣壳蛋白及其用途 | |
| CN118955653A (zh) | 腺相关病毒衣壳蛋白的突变体、编码其的核酸及应用 | |
| WO2020214526A1 (en) | Enhanced transduction of aav vectors encoding micrornas | |
| HK1208683B (en) | High-transduction-efficiency raav vectors, compositions, and methods of use |